Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EFFICACY: Insulin Detemir vs Glargine in T2D
NCT00909480Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- May 2009
- Primary completion
- Jun 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 6
01
Overview
A Phase 4 trial of insulin detemir in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started May 2009; status: completed.
02
Drugs
insulin detemir
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00909480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00909480.